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Angiotensin Il-Induced Oxidative Stress Resets the Ca2+ 
Dependence of Ca2+-Calmodulin Protein Kinase II and 
Promotes a Death Pathway Conserved Across 
Different Species
Julieta Palomeque, Omar Velez Rueda, Luciana Sapia, Carlos A. Valverde, Margarita Salas, 
Martin Vila Petroff, Alicia Mattiazzi
Rationale: Angiotensin (Ang) Il-induced apoptosis was reported to be mediated by different signaling molecules. 
Whether these molecules are either interconnected in a single pathway or constitute different and alternative 
cascades by which Ang II exerts its apoptotic action, is not known.
Objective: To investigate in cultured myocytes from adult cat and rat, 2 species in which Ang II has opposite 
inotropic effects, the signaling cascade involved in Ang Il-induced apoptosis.
Methods and Results: Ang II (1 ptmol/L) reduced cat/rat myocytes viability by '»40%, in part, because of apoptosis 
(TUNEL/caspase-3 activity). In both species, apoptosis was associated with reactive oxygen species (ROS) 
production, Ca2+/calmodulin-dependent protein kinase (CaMK)II, and p38 mitogen-activated protein kinase 
(p38MAPK) activation and was prevented by the ROS scavenger MPG (2-mercaptopropionylglycine) or the 
NADPH oxidase inhibitor DPI (diphenyleneiodonium) by CaMKII inhibitors (KN-93 and AIP [autocamtide 
2-related inhibitory peptide]) or in transgenic mice expressing a CaMKII inhibitory peptide and by the 
p38MAPK inhibitor, SB202190. Furthermore, p38MAPK overexpression exacerbated Ang Il-induced cell 
mortality. Moreover, although KN-93 did not affect Ang Il-induced ROS production, it prevented p38MAPK 
activation. Results further show that CaMKII can be activated by Ang II or H2O2, even in the presence of the 
Ca2+ chelator BAPTA-AM, in myocytes and in EGTA-Ca2+-free solutions in the presence of the calmodulin 
inhibitor W-7 in in vitro experiments.
Conclusions: (1) The Ang Il-induced apoptotic cascade converges in both species, in a common pathway mediated by 
ROS-dependent CaMKII activation which results in p38MAPK activation and apoptosis. (2) In the presence of Ang 
II or ROS, CaMKII may be activated at subdiastolic Ca2+ concentrations, suggesting a new mechanism by which ROS 
reset the Ca2+ dependence of CaMKII to extremely low Ca2+ levels. (Circ Res. 2009;105:1204-1212.)
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Experimental evidence indicates that a critical factor in the transition from compensated to noncompensated cardiac 
hypertrophy is myocyte cell loss by apoptosis.1 The circulat­
ing levels of Ang II are increased in heart failure and may 
constitute one of the major causes of cell death in this 
transition.2 The apoptotic effects of Ang II have been reported 
to be mediated by different signaling molecules, eg, Ca2+, 
protein kinase (PK)C-b, p38 mitogen-activated protein kinase 
(p38MAPK), or reactive oxygen species (ROS).15 Recent 
reports have shown that activation of the multifunctional 
Ca2+/calmodulin-dependent protein kinase (CaMK)II is a 
common intermediate of diverse death stimuli-induced apo­
ptosis in cardiac cells.6 Supporting these results, we have 
demonstrated that CaMKII activation is a critical event in the 
signaling cascade that leads to apoptosis and necrosis occur­
ring in reperfusion injury.7 More importantly, we and others 
have shown that Ang Il-induced apoptosis is caused by an 
increase in CaMKII activity mediated by ROS.6 '' Recent exper­
imental evidence further indicated that ROS-induced oxidation 
of methionine residues sustains CaMKII activity in the absence 
of Ca2 /calmodulin (Ca2 /CaM). However, this action requires 
previous binding of Ca2 /CaM to expose the autoinhibitory 
domain of CaMKII for oxidation.8 Although these experiments 
suggest the concept that ROS can reset the Ca2 dependence of 
CaMKII activation, this possibility has never been tested. More­
over, other findings have pointed to the role of phosphatase 
inhibition in ROS-induced CaMKII activation.10
In spite of these important achievements in the understanding 
of the proapoptotic molecules activated by Ang II, the signaling 
cascade whereby the peptide produces apoptosis remains uncer-
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Non-standard Abbreviations and Acronyms
AC3-I autocamtide-3-derived inhibitory peptide
AC3-C autocamtide-3- derived control peptide
Ang II angiotensin II
Ca2+, intracellular calcium
CaJ intracellular calcium transient
CaM calmodulin
CaMKII Ca2 /calmodulin-dependent protein kinase II
DPI diphenyleneiodonium
IP3 inositol triphosphate
P phosphorylated
P38MAPK p38 mitogen-activated protein kinase
ROS reactive oxygen species
SB SB202190
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tain. For instance, it is not clear whether the proapoptotic 
molecules mentioned above are interconnected in one single 
pathway initiated by Ang II or whether they constitute part of 
different and alternative cascades by which Ang II exerts its 
apoptotic action. To examine this issue, we investigated the 
signaling cascade by which Ang II produces cell death in 
cultured cardiomyocytes from rat and cat, 2 species in which 
Ang II produces opposite effects on cardiac contractility.1112 
The results presented herein, using pharmacological tools and 
genetic manipulation, show that species with opposite inotropic 
response to acute Ang II administration share a common 
apoptotic pathway triggered by the sustained stimulation with 
the peptide, involving ROS, CaMKII, and p38MAPK. Although 
these molecules have been previously implicated in the apoptotic 
effect of Ang II, the present findings demonstrate that they 
constitute a previously undefined cascade of concatenated events 
that lead to apoptosis. More importantly, the results indicate that 
in the presence of ROS, CaMKII may be activated in nominally 
Ca2 -free conditions. These results reveal a new mechanism by 
which ROS radically reset the Ca2 dependence of CaMKII to 
extremely low values.
Methods
Adult cats. Wistar rats, or transgenic mice expressing either a CaMKII 
inhibitory peptide (AC3-I) or a scrambled control peptide (AC3-C)8 
were used in accordance with the Guide for the Care and Use of 
Laboratory Animals (NIH Pubheation No.8-23. revised 1996).
An expanded Methods section is available in the Online Data 
Supplement at http://circres.ahajournals.org.
Results
ROS- and CaMKII-Dependent Ang
II—Induced Apoptosis
Figure 1A shows that 1 /rim >1/1. Ang II significantly reduced 
the number of viable rat and cat myocytes to 38.9±2.6% and 
43.7±3.0%, respectively, after 24 hours of culture. This was 
prevented in cat myocytes by the Ang II type 1 receptor 
blocker losartan but not by the AT2 receptor antagonist 
PD123.319 (41.9±2.9%, P<0.05 versus control). Figure IB 
and 1C shows that Ang II increased caspase-3 activity and the 
number of TUNEL-positive nuclei in cat myocytes. Overall, 
TUNEL-positive nuclei increased from 3.9±0.2% to 
10.l±0.1% (P<0.05, control versus Ang II), confirming the 
apoptotic effect of sustained Ang II administration.2
Figure ID depicts typical experiments and overall results 
showing that Ang II increased ROS production in rat cells. 
This effect was prevented by 10 jumol/L of the flavoprotein 
inhibitor diphenyleneiodonium (DPI). Moreover, cotreatment 
of either rat or cat myocytes with Ang II plus DPI or the free 
radical scavenger MPG (2-mercaptopropionylglycine) 
(1 mmol/L) prevented cell death (Figure IE).
Figure 2A depicts immunofluorescence images from cat 
cultured myocytes, showing that phosphorylated (P)-CaMKH 
was increased by Ang II. This increase was prevented by
I /imo I/I. of the CaMKII inhibitor KN-93 but not by the inactive 
analog KN-92. Similarly, KN-93 prevented the increase in 
P-CaMKH and P-Thrl7 of phospholamban, a CaMKII substrate, 
when evaluated by Western blots (Figure 2B). KN-93, when 
given alone, failed to significantly affect basal CaMKII activity, 
as assessed by P-Thrl7 (82.2±16.5% of control, n=7). Figure 
2C shows that CaMKII inhibition did not prevent the increase in 
ROS production induced by Ang II in rat myocytes, indicating 
that Ang Il-induced ROS formation is upstream of CaMKII. 
Figure 2D depicts overall results showing that CaMKII inhibi­
tion, either by KN-93 or by a more specific CaMKII inhibitor, 
AIP (autocamtide 2-related inhibitory peptide) (2.5 jumol/L) also 
prevented Ang Il-induced cell death in both, cat and rat 
myocytes. Moreover, transgenic myocytes expressing the 
CaMKII inhibitory peptide (AC3-I) were protected from the 
deleterious effect of Ang II when compared with myocytes 
expressing the scrambled control peptide (AC3-C). The images 
on the right of Figure 2D depict representative experiments 
showing that CaMKII inhibition prevents the increase in 
caspase-3 activation and TUNEL-positive cells. Overall, 
TUNEL-positive nuclei decreased from 10.1±0.1% to 
5.73±0.5% and caspase-3 activity from 57.9± 17.9% to 
27.5±13.9% (Ang II versus Ang 11+KN-93).
Taken together, these results indicate that ROS and CaMKII 
activation are necessary steps of the pathway by which Ang II 
induces apoptosis, both in cat and rat myocardium.
Ang Il-Induced ROS-Dependent Activation of 
CaMKII Occurs Even in a Nominally
Ca2+i-Free Medium
Results show that prolonged exposure of rat myocytes to Ang
II is associated with the activation of CaMKII. However, the 
source of Ca2 for CaMKII activation is not straightforward 
in cultured unpaced myocytes. To assess this issue, we 
evaluated diastolic Ca2 and Ca2 , transient amplitude (CatT) 
in electrically field stimulated (0.5 Hz) rat cells, after 24 
hours of culture. Ang II did not modify neither diastolic Ca2 
nor peak Ca,T in rat myocytes (diastolic Indo-1 fluorescence, 
0.72±0.05 and 0.70±0.05; peak fluorescence, 1.34±0.04 
and 1.35±0.05, control versus Ang II). Similarly, sustained 
administration of Ang II failed to increase diastolic Ca2 or 
Ca,'!’ amplitude in cat myocytes, a species in which acute 
administration of Ang II effectively increases Ca2 , (Figure 
3A and 3B).11 Furthermore, estimation of sarcoplasmic retic­
ulum Ca2 content by caffeine pulses showed that there was 
no significant differences between control and Ang II treated 
cells. In contrast, myocytes stimulated for 24 hours with
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Figure 1. Ang ll-induced myo­
cyte apoptosis is dependent on 
ROS production. A, Cell viability 
was significantly reduced after 
24 hours of culture in the pres­
ence of 1 /xmol/L Ang II (n=12 
and 16 for rat and cat, respec­
tively). B, Representative blots 
and average data showing that 
Ang II increased the amount of 
the 17-kDa cleavage product of 
caspase-3, indicating caspase-3 
activation (n=6). Blots were nor­
malized to actin. C, Typical 
example of the increase in 
TUNEL-positive cells produced 
by Ang II in cat myocytes. D, 
Representative photographs 
(left) and average data (right) 
(n=4), showing the increment in 
DM-H2DCFDA fluorescence in 
myocytes treated with Ang II in 
the presence and absence of 
DPI. DPI alone did not signifi­
cantly affect DM-H2DCFDA fluo-
rat and cat myocytes viability was significantly prevented by DPIrescence. E, Mean results showing that Ang
and MPG (2-mercaptopropionylglycine) (n=4 to 6 for each group). In this and the following figures overall data represents means± 
SEM *P<0.05 vs control.
1 gmo I/I. isoproterenol (an intervention known to promote 
Ca2 -dependent apoptosis13) showed a significant increase in 
the amplitude of the Ca,T and sarcoplasmic reticulum Ca2 
content (Figure 3C). Diastolic Ca2 was also measured every 
10 minutes during the first hour of incubation with Ang II and 
every hour in the following 4 hours, to exclude the existence 
of a possible transitory increase in Ca2 , at the beginning of 
the incubation period, undetectable after 24 hours of Ang II 
stimulation but still responsible for Ang Il-induced CaMKII 
activation. Again, no increase in Ca2 , was detected in Ang 
Il-treated cells with respect to controls in 4 experiments in 
which at least 20 cells were observed at each time point 
(Figure 4A). These experiments indicate that there was no 
significant increase in Ca2 , in unpaced myocytes with 
sustained Ang II stimulation, suggesting that Ang Il-induced 
CaMKII activation could occur in the absence of any increase 
in Ca2 ,. Because Ang II increases inositol triphosphate (IP3), 
it is conceivable that the peptide could produce a compart­
mentalized increase in Ca2 through the IP3 receptors, 
undetectable when measuring bulk cytosolic Ca2 . To ex­
plore this possibility, rat myocytes were cultured in the 
presence and absence of 25 /xmol/L 2-APB (2- 
aminoethoxydiphenyl borate), an IP3 receptor inhibitor.14 
2-APB did not prevent Ang II induced cell death: cell 
viability was 38.9±2.6% (Ang II) versus 36.0±3.2% (2- 
APB+Ang II) (n=4). These results make unlikely the pos­
sibility of a restricted increase in Ca2 produced by IP3 being 
the source for CaMKII activation. The effect of Ang II on cell 
viability and CaMKII activity was also assessed in the 
presence of 1 jumol/L of the Ca2 chelator BAPTA-AM. 
BAPTA-AM was added to the culture when the cells were 
plated. After 1 hour, the medium was changed for a fresh 
medium containing 1 jumol/L BAPTA-AM and Ang II±KN- 
93. Control experiments showed that this concentration of 
BAPTA-AM prevented cell death and the increase in Ca2 
levels induced by exposing the cells to the Ca2 ionophore 
A23128 (Figure 4B). Furthermore, BAPTA abolished twitch 
contraction and the associated Ca,T and decreased Indo-1 
ratio to values lower than the initial resting levels in electri­
cally stimulated myocytes (results not shown). These exper­
iments indicate that BAPTA-AM was properly loaded into 
the cell and that Ca2 levels reached subdiastolic values in 
the presence of BAPTA-AM. Figure 4C shows that Ang II 
induced a decrease in cell viability and an increase in CaMKII 
activity and that these effects could be prevented by KN-93. 
Because Ang II increases ROS (Figure ID), we assessed 
whether ROS could promote CaMKII activation and apopto­
sis in the presence of BAPTA-AM by measuring P-CaMKII 
and caspase-3 activity by fluorescence microscopy in myo­
cytes stimulated with 200 jumol/L H2O2. Both P-CaMKII and 
caspase-3 activity were increased by H2O2 and again these 
increases were prevented by cotreatment with KN-93 (Figure 
4D). These results indicate that Ang Il-induced ROS produc­
tion may activate CaMKII even at subdiastolic Ca2 levels.
To further explore whether the effect of ROS on CaMKII 
activation was attributable to a direct action of ROS on CaM, 
we performed experiments in isolated myocytes and in 
cardiac homogenates in vitro with the CaM inhibitor W-7. 
Figure 5A and 5B show that in cultured myocytes pretreated 
with BAPTA-AM, W-7 failed to affect H2O2-induced cell 
death and CaMKII activity (P-CaMKII and P-Thrl7), 
whereas KN-93 prevented both effects. Of note, control 
experiments showed that when given alone, H2O2 produced 
an increase in CaMKII activity (assessed by P-Thrl7 site of 
phospholamban) of 224±51% (n=3) that was associated 
with the decrease in cell viability observed in Figure 5A. 
BAPTA-AM, KN-93, and W-7 failed to significantly affect 
basal CaMKII activity when given alone. Similar results to 
those obtained in myocytes were obtained in vitro where 
H2O2 increased P-CaMKII in a nominally Ca2 -free medium 
(0 Ca2 -EGTA). both in the absence or in the presence of 
W-7 and no exogenous addition of CaM (Figure 5C). These
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Figure 2. CaMKII activation induced by sustained stimulation with Ang II produces cell death and is dependent on ROS production. A, 
Immunofluorescence staining with anti P-CaMKII antibody shows increased fluorescence in cat myocytes in the presence of Ang II. The 
increase in fluorescence was reduced by the concomitant treatment with KN-93. KN-92 did not affect Ang Il-induced increase in immu­
nofluorescence. Similar results were obtained in 2 other independent experiments. B, Typical blots and average data showing the 
increase in CaMKII activity produced by Ang II, assessed by the increase in P-CaMKII and its substrate, P-Thr17 of phospholamban. 
The increase in both phosphoproteins was prevented by KN-93 (n=9). C, Fluorescent images and average results showing that KN-93 
does not affect Ang Il-induced DM-H2DCFCA fluorescence (n=4). D, Average results from cultured cat, rat and transgenic myocytes 
showing the increase in mortality produced by Ang II in control conditions and its prevention by CaMKII inhibition with KN-93 or AIP 
(autocamtide 2-related inhibitory peptide) or by using transgenic mice expressing a CaMKII inhibitory peptide (AC3-I) (n=3 to 7 for each 
group). On the right, typical Western blots showing the effect of Ang II on the activation of caspase-3. Bottom, Fluorescent images 
showing the increase in the number of TUNEL-positive cells induced by Ang II and its prevention by KN-93. In B and D, blots were nor­
malized to actin. *P<0.05 vs Ang II alone.
D
results were obtained in homogenates from nonbeating hearts 
perfused with low Ca2 . nifedipine and EDTA, to favor Ca2 , 
depletion, and in the presence of 1 to 10 mmol/L of EGTA in the 
in vitro phosphorylation assay. Because CaM is a protein with 
many methionine residues susceptible to oxidation,15 we cannot 
exclude the possibility that the lack of effect of W-7 could be 
attributable to the fact that oxidized CaM becomes resistant to 
the inhibitory effects of W-7. However, in in vitro experiments, 
W-7 was effective in diminishing by 60.8±9.9% the increase in 
P-CaMKII produced by Ca2 addition in the presence of H2O2.
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Figure 3. Sustained Ang II 
stimulation does not modify 
Ca2 handling. Typical records 
of Ca,T and caffeine pulses 
(Caff) from adult cat cultured 
myocytes in control conditions 
(A), treated with Ang II (B), or 
treated with isoproterenol (Iso) 
(C) (top). The insets depict 
individual Ca,T in an expanded 
time scale to show that the 
failure of Ang II to increase 
Ca^ amplitude cannot be 
attributed to incomplete relax­
ation of the twitches. Bottom, 
Average values of these exper­
iments. *P<0.05 vs the other 2 
groups (n=12 cells/per group 
from 4 different hearts).
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These results would support the view that W-7 is able to inhibit 
CaM, even in the presence of H2O2 and would indicate that ROS 
can either directly activate CaMKII or shift the Ca2 /CaM 
dependence of CaMKII to extremely low Ca2 and CaM values.
p38MAPK Activation Is Required for Ang 
Il-Induced Cell Death
p38MAPK mediates apoptosis in several models of cardiac 
stress.1617 To evaluate the role of p38MAPK in Ang II- 
induced apoptosis, 2 different approaches were used: (1) rat 
and cat myocytes were cultured with Ang II± 10 jumol/L of 
the p38MAPK inhibitor SB202190 (SB) (Figure 6A) and (2) 
gene transfer was performed to overexpress p38MAPK 
(Adv.p38) in rat myocytes (Figure 6B). In these experiments, 
/3-galactosidase (Adv./3gal) was overexpressed to serve as 
control. Figure 6A shows that SB protected cat cardiomyo­
cytes from the deleterious effect of Ang II. Similar results 
were obtained in rat cells (data not shown). Figure 6B shows 
that after 24 hours, cells infected with the adenovirus robustly 
expressed the reporter gene green fluorescent protein (GFP), 
indicating that the gene of interest was also overexpressed. 
Results show that although the viability of the p38MAPK- 
overexpressing cells was not different from that in /3-galac- 
tosidase-overexpressing cells under control conditions, cells 
infected with Adv.p38 and incubated with Ang II showed 
reduced viability compared to /3-galactosidase cells. These 
experiments reveal that p38MAPK is involved in Ang II- 
induced cell death. Figure 6C further shows that the increase 
in the activity of p38MAPK induced by Ang II was com­
pletely prevented by KN-93. However, SB failed to affect 
Ang Il-induced CaMKII activity (Ang II: 194.1±26.8% of 
control; Ang II+SB: 180.9±21.5% of control). These find­
ings indicate that activation of p38MAPK is downstream of 
CaMKII in the Ang Il-induced apoptotic signaling cascade.
Discussion
Ang II has been shown to be implicated in many cellular 
physiological and pathological processes. In the near term, 
Ang II has been shown to modulate contractility and excita­
tion-contraction coupling. Recent experiments demonstrated 
that the positive and negative inotropic effects of the peptide 
occur through different mechanisms. Whereas the positive 
inotropic effect was associated with an increase in intracel­
lular Ca2 ,11J' negative inotropism occurs in the rat, because 
of a p38MAPK-mediated decrease in myofilament Ca2 
responsiveness.12 In the long term, Ang II has been associated 
with cardiomyocyte apoptosis. Since the pioneering studies of 
Anversa, this apoptotic action was associated with an increase 
in Ca2 ,.2 From then, different molecules have been sug­
gested to mediate the apoptotic effects of Ang II.4-518 How­
ever, all of these previous reports failed to explore the 
sequence of events triggered by angiotensin II type 1 receptor 
activation that culminate in apoptotic cell death. The present 
results describe for the first time a sequence of concatenated 
events by which Ang II produces apoptosis. More impor­
tantly, the results indicate that activation of CaMKII may 
occur at subdiastolic Ca2 , levels. Finally, it is shown that 
this pathway is common to species in which Ang II has 
opposite inotropic effects. Thus, the interspecies differences 
observed in the contractile effect of Ang II, appear to be 
absent in its apoptotic action, suggesting that a similar 
apoptotic cascade induced by Ang II may be operative across 
a wide range of species, including the human.
Ang Il-Induced Apoptotic Cell Death Involves 
ROS-Dependent Activation of CaMKII
The present results demonstrate that Ang II induces ROS 
production in association with an increase in CaMKII activity. 
The inhibition of ROS and the prevention of CaMKII activation 
were both able to inhibit Ang Il-induced cell death. Moreover, 
KN-93 diminished CaMKII phosphorylation and myocyte apo­
ptosis without affecting ROS production, indicating that ROS 
are upstream of CaMKII (Figures 1 and 2). These results fully 
confirm the recently discovered ROS-induced CaMKII activa­
tion in the apoptotic cascade of Ang II.8-919
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Figure 4. Ang II activation of CaMKII occurs in a nominally Ca2 -free medium. A, Average data from unpaced rat myocytes showing 
that Ang II did not affect diastolic Ca2 levels during the first 4 hours of treatment. B, Mean results showing cat cell viability and indo-1 
diastolic fluorescence in the presence of the Ca2 ionophore A23128±BAPTA-AM. C, Average data of viable cells and P-CaMKII from cat 
myocytes in the absence and presence of BAPTA-AM, treated with Ang ll±KN93. Blots were normalized to GAPDH (n=4 in each group). D, 
Average results from fluorescence analysis of caspase-3 activity and P-CaMKII in cat cells in the presence of BAPTA-AM and stimulated with 
H2O2±KN-93. P-CaMII fluorescence data were expressed as mean fluorescence intensities. *P<0.05 vs the other groups.
CaMKII Activity Can Be Increased by ROS in 
Nominally Ca^-Free Conditions and After 
Inhibition of CaM
Recent experiments indicate that sustained activation of CaMKII 
by ROS occurs by a modification of CaMKII at M28I/282 
residues. CaMKII activation by ROS appears to require previous 
“opening” of the kinase by Ca2 /CaM to allow access to the 
autoinhibitory domain for oxidation.8 Because our experiments 
were performed in quiescent myocytes, the source of Ca2 
required to initially activate the kinase was not obvious. Indeed, 
when Ca2 , was measured in both species after 24 hours of Ang 
II stimulation, no increases in either diastolic and systolic Ca2 
or sarcoplasmic reticulum Ca2 content was detected in stimu­
lated myocytes (Figure 3). These results prompted us to explore 
in depth the putative source of activating Ca2 . considering 
different hypotheses. (1) The increase in Ca2 occurred within 
the first hours during the culture period. This possibility is 
supported by experiments describing an increase in diastolic 
Ca2 after incubation with Ang II.2 (2) There is a compartmen­
talized increase in Ca2 . not detectable by our epifluorometric 
measurements of global cytosolic Ca2 but nevertheless able to 
activate CaMKII. A release of Ca2 by IP, receptors is a 
putative mechanism by which Ang II may produce a restricted 
increase in Ca2 ,.2I) (3) ROS may alter the affinity of CaM for 
CaMKII. It is known that CaM weakly associates with the CaM 
binding domain of the kinase even before binding to Ca2 21 and 
several cellular processes are regulated by Ca2 -free CaM.22 (4) 
Ang II does not affect basal Ca2 levels but, through the increase 
in ROS, produces an inhibition of phosphatases that would allow 
the phosphorylation of CaMKII at resting Ca2 . This possibility
1210 Circulation Research December 4, 2009
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Figure 5. H2O2 induces CaMKII activation in the presence of 
BAPTA-AM and W-7. A, Average data of cat cell viability indi­
cating that H2O2 is able to induce cell death mediated by 
CaMKII activation even in the presence of the Ca2 chelator 
BAPTA-AM and after CaM inhibition. B, Typical blots and aver­
age data from cell cultures showing the increment in the phos­
phorylation of CaMKII (P-CaMKII) and Thr17 of phospholamban 
(P-Thr17) because of H2O2 stimulation in the presence of 
BAPTA-AM and W-7. C, Mean data of in vitro CaMKII phos­
phorylation induced by H2O2 in the presence of EGTA and W-7 
in cardiac homogenates. *P<0.05 vs the other groups.
was suggested in lymphocytes.10 (5) There might be conditions 
in which ROS may activate CaMKII directly without the 
requirement of Ca2 /CaM. (6) ROS may radically reset the 
CaMKII Ca2 dependence to subphysiologic al values.
The first 2 hypotheses are not supported by the present results 
because: (1) we did not detect any significant increase in 
diastolic Ca2 levels during the first 4 hours of incubation with 
Ang II and (2) inhibition of IP, receptors failed to prevent Ang 
Il-induced cell death. More importantly, incubation of myocytes 
with BAPTA-AM or of cardiac homogenates with 0 Ca2 - 
EGTA was unable to inhibit both cell death and CaMKII 
activation induced by Ang II and H2O2. which makes an 
undetected compartmentalized increase in Ca2 an unlikely 
candidate. The finding that the inhibition of CaM with W-7 in 
the presence of BAPTA-AM did not affect H2O2-induced 
CaMKII phosphorylation (Figure 5) would exclude the third 
possibility, ie, a direct CaM regulation by ROS. Indeed, recent 
experiments showed that oxidation of CaM diminishes rather 
than induces CaM-dependent CaMKII activation.23 The fourth 
possibility, ie, an increase in CaMKII activity caused by a 
ROS-induced phosphatase inhibition able to increase the phos­
phorylated state of the kinase, is hard to reconcile with the fact 
that autophosphorylation of the kinase requires previous activa­
tion.24 An inhibition of phosphatases would only be able to 
increase CaMKII activity, measured as P-CaMKII, if the kinase 
was previously activated to trigger its autophosphorylation (see 
further discussion below). According to this, one might con­
clude, at first sight, that Ang II induces a Ca2 /CaM-indepen- 
dent ROS-dependent activation of CaMKII in isolated myo­
cytes. There are at least 3 main reasons, however, that strongly 
conspire against this possibility. First, experiments by Anderson 
and colleagues clearly showed that an increase in Ca2 4 is a 
prerequisite to produce Ang Il-induced CaMKII activation.8 
Second, although we used different strategies to decrease Ca2 ,, 
we are aware of the fact that a complete Ca2 , depletion is 
virtually impossible in living systems.25 Third, we were able to 
prevent Ang Il-dependent CaMKII activation by KN-93, 
known to inhibit CaMKII by competing with Ca2 /CaM. Thus, 
our results strongly suggest that the presence of ROS resets the 
dependence of CaMKII to Ca2 to extremely low, subdiastolic 
Ca2 , levels. In this scenario, it is conceivable that an inhibition 
of phosphatases by ROS could also contribute to sustained 
CaMKII activation.10 In line with this idea, recent experiments 
indicate the need of phosphatase inhibition for the progression of 
CaMKII autophosphorylation.26 Of note, buffering Ca2 , 
(EGTA or BAPTA-AM) (Figures 4 and 5) may decrease the 
activity of the Ca2 -dependent phosphatase PP2B, which, by 
increasing inhibitor-1 phosphorylation, would inhibit PPI, one 
of the main phosphatases negatively involved in CaMKII phos­
phorylation.27 This mechanism may be responsible for part of 
the basal phosphorylation levels of CaMKII or Thrl7 site of 
phospholamban observed under these conditions. A contribution 
of phosphatases to the enhanced phosphorylation of these 
proteins over basal values, under the same Ca2 buffering 
conditions or in the presence of phosphatase inhibitors (Figure 
5C), is more difficult to conceive. However, based on the present 
results their contribution cannot be completely excluded.
Apoptotic Role of p38MAPK
Our results using SB and Ad.p38 demonstrate that p38MAPK is 
a crucial step in the apoptotic cascade triggered by sustained 
Ang II stimulation. Because KN-93 significantly decreased 
p38MAPK activity, whereas SB has no effect on Ang II-
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induced CaMKII activity, p38MAPK would be located down­
stream CaMKII activation (Figure 6). The potential for CaMKII 
to activate p38MAPK is not unique to this study. Several reports 
have shown that p38MAPK can be regulated by CaMKII 
through the activation of different intermediate molecules, in­
cluding, apoptosis signal-regulating kinase l,28 lanus kinase 2,29 
and protein kinase R.30 Although the signaling sequence down­
stream of p38MAPK was not studied in the present experiments, 
previous reports indicate that CaMKII activates p38MAPK,29 
which, in turn, activates mitochondrial death pathway by pro­
ducing an unbalance between the expression of pro- and antiapo- 
ptotic proteins, Bax and Bcl-2.31 These results would suggest a 
downstream location of p38MAPK in the cascade of events 
initiated by Ang II that leads to apoptosis.
In summary, the present results describe for the first time the 
sequence of events whereby Ang II mediates apoptosis in
Figure 6. p38MAPK activation 
is responsible for Ang II—in­
duced cell death and is 
dependent on CaMKII activa­
tion. A, Representative photo­
graphs and average data from 
cat myocytes showing that the 
Ang Il-induced reduction in 
cell viability can be prevented 
by the p38MAPK inhibitor SB 
(n=4 in each group). B, Repre­
sentative photographs and 
average results of rat myo­
cytes transfected with Ad./3gal 
or Ad.p38. Green fluorescent 
protein (GFP) fluorescence 
indicates that the transfection 
efficiency (upper) and bright 
field images (lower) are repre­
sentative of the effect of Ang II 
on cell viability in /3gal and 
p38MAPK-overexpressing 
cells. Bar graph shows the 
average results of these exper­
iments (n=3). *P<0.05 vs 
Ad./3gal; §P<0.05 vs Ad.p38. 
C, Typical blots and average 
data of the effect of Ang II on 
p38MAPK activity. Effect of 
Ang ll±KN-93 on p38MAPK 
activation. *P<0.05 vs the 
other groups (n=6).
cardiac cells. In this cascade, Ang Il-induced ROS production 
appears as the initial trigger for the subsequent activation of 
CaMKII and the onset of the apoptotic process. The results 
presented herein further demonstrate that in the presence of 
ROS, activation of CaMKII may occur without the need of the 
conventional increase in Ca2 and only requires extremely low 
Ca2 /CaM levels, revealing a novel and previously unrecog­
nized mode of CaMKII activation in which ROS reset the Ca2 
dependence of CaMKII to subphysiological concentrations. 
Finally, this study shows that the Ang Il-induced signaling 
pathway that results in cardiomyocyte apoptosis is conserved 
across different species and is operative independently of the 
inotropic responses elicited by the peptide. It is tempting to 
speculate that similar apoptotic signaling could occur and even 
be exacerbated in the failing heart, where Ang II levels, as well 
as CaMKII and p38MAPK activities, are increased.
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